Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
Pisani, E, Nistor, A, Hasnida, A, Parmaksiz, K, Xu, J and Kok, MO.
2019.
Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.
[Online].
Harvard Dataverse.
Available from:
https://doi.org/10.7910/DVN/0GGI9D
Pisani, E, Nistor, A, Hasnida, A, Parmaksiz, K, Xu, J and Kok, MO.
Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
[Internet].
Harvard Dataverse;
2019.
Available from:
https://doi.org/10.7910/DVN/0GGI9D
Pisani, E, Nistor, A, Hasnida, A, Parmaksiz, K, Xu, J and Kok, MO
(2019).
Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.
[Data Collection].
Harvard Dataverse.
https://doi.org/10.7910/DVN/0GGI9D
Description
This dataset contains supporting data for a study of the political and economic drivers of substandard and falsified medicines in middle income countries, led by Elizabeth Pisani. The full title of the paper is: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania. (2019-04-08)